Osteopore Ltd. ( (AU:OSX) ) just unveiled an update.
Osteopore Limited has announced the date for its Annual General Meeting, set for May 30, 2025. The meeting will include the re-election and appointment of directors, with nominations closing on April 18, 2025. This announcement is part of Osteopore’s ongoing efforts to strengthen its leadership and maintain its position as a leader in the regenerative medicine industry, potentially impacting its strategic direction and stakeholder relations.
More about Osteopore Ltd.
Osteopore Ltd. is a global medical technology company founded in Singapore and listed in Australia, specializing in the commercialization of 3D-printed biomimetic and bioresorbable implants. The company’s technology focuses on enabling natural bone healing through patented micro-structured scaffolds that dissolve over time, reducing complications associated with permanent implants.
YTD Price Performance: -50.0%
Average Trading Volume: 298,153
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$2.42M
For detailed information about OSX stock, go to TipRanks’ Stock Analysis page.